Trial Profile
Quality of Life With Arcoxia in Women With Dysmenorrhea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Dysmenorrhoea
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 16 Mar 2015 Trial phase changed from III to IV as reported by ClinicalTrials.gov record.
- 17 Nov 2006 New trial record.